loss of respiration in Escherichia. coli showed a ~1000 fold reduction in the number of 67 persisters in stationary phase (Orman and Brynildsen 2015) . 68
To search for potential antibacterial targets, we previously built a conditional growth 69 mutant library of the clinically relevant strain B. cenocepacia K56-2 (Table 1) (Lee et al. 2015) . These findings prompted us 83 to investigate whether the essential ETF could be considered as an antibacterial target. 84
Although the reasons for ETF essentiality are unknown in Bcc, many ETFs are 85 components of the fatty acid metabolism pathway (Fujita et al. 2007 days by visually counting dead and live worms for each well and the average was 113 calculated for each condition. Fig. 1 illustrates a representative survival curve of three 114 biological replicates. When the worms were kept in liquid medium supplemented with 115 0.2% rhamnose (Fig. 1A) C. elegans infected with either WT or CGetf bacterial strains 116 showed similar survival rates, less than 50% individuals survived after four days. This 117 result indicates that rhamnose reached the nematode's gut and induced ETF expression, 118 allowing bacterial proliferation in the gut. Infection in these conditions was comparable 119
to that of the wild type strain. Conversely, in the absence of rhamnose, the individuals 120 infected with CGetf recovered from the infection with a survival rate close to 100% ( EtfB subunit (Fig. 3C) . When the protein synthesis was carried out in the presence of any 174 of the four ODNs tested, no protein band was observed in the gel. All the four ODNs 175 were able to inhibit the production of ETF protein in vitro. However, practical utilization 176 of antisense oligonucleotides as drugs require them to resist the action of the ubiquitous 177 nucleases and to penetrate the cell membrane to reach the bacterial cytosol. The former 178 of other cell penetrating peptides may clarify the causes of the lack of activity of the 217 compounds used in this work and provide with active compounds capable of inhibition of 218 growth of B. cenocepacia. These studies will also permit to start defining peptides and 219 analogs that are appropriate for each particular bacterial species. 220
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